141 related articles for article (PubMed ID: 2575000)
21. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors.
Fuqua SA; Hill SM; Chamness GC; Benedix MG; Greene GL; O'Malley BW; McGuire WL
J Natl Cancer Inst; 1991 Aug; 83(16):1157-60. PubMed ID: 1679459
[TBL] [Abstract][Full Text] [Related]
22. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
23. An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.
Lehrer SP; Schmutzler RK; Rabin JM; Schachter BS
Breast Cancer Res Treat; 1993; 26(2):175-80. PubMed ID: 8219254
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.
Andersen TI; Heimdal KR; Skrede M; Tveit K; Berg K; Børresen AL
Hum Genet; 1994 Dec; 94(6):665-70. PubMed ID: 7989041
[TBL] [Abstract][Full Text] [Related]
25. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.
Berryman IL; Harvey JM; Sterrett GF; Papadimitriou JM
Anal Quant Cytol Histol; 1987 Oct; 9(5):429-34. PubMed ID: 3675802
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
27. Altered restriction pattern of the putative DNA binding domain of estrogen receptor or related genes in primary human meningiomas.
Vacca A; Fazio VM; Gandini O; Oppido P; Delfini R; Frati L; Gulino A
Int J Cancer; 1989 Apr; 43(4):567-9. PubMed ID: 2703268
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
[TBL] [Abstract][Full Text] [Related]
29. Feline adult beta-globin polymorphism reflected in restriction fragment length patterns.
Kohn B; Henthorn PS; Rajpurohit Y; Reilly MP; Asakura T; Giger U
J Hered; 1999; 90(1):177-81. PubMed ID: 9987927
[TBL] [Abstract][Full Text] [Related]
30. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.
Murphy LC; Dotzlaw H
Mol Endocrinol; 1989 Apr; 3(4):687-93. PubMed ID: 2725532
[TBL] [Abstract][Full Text] [Related]
31. Correlation between histopathologic features and estrogen receptor status in primary breast cancer.
Mantouvalos H; Makrygiannakis A; Metallinos C; Yianniou A; Gouskos A
Int J Gynaecol Obstet; 1984 Jun; 22(3):177-9. PubMed ID: 6148273
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.
Gennari L; Becherini L; Masi L; Mansani R; Gonnelli S; Cepollaro C; Martini S; Montagnani A; Lentini G; Becorpi AM; Brandi ML
J Clin Endocrinol Metab; 1998 Mar; 83(3):939-44. PubMed ID: 9506753
[TBL] [Abstract][Full Text] [Related]
33. Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology.
Carmeci C; deConinck EC; Lawton T; Bloch DA; Weigel RJ
Am J Pathol; 1997 May; 150(5):1563-70. PubMed ID: 9137083
[TBL] [Abstract][Full Text] [Related]
34. Mucopolysaccharidosis IVA: structural gene alterations identified by Southern blot analysis and identification of racial differences.
Tomatsu S; Fukuda S; Cooper A; Wraith JE; Uchiyama A; Hori T; Nakashima Y; Yamada N; Sukegawa K; Kondo N
Hum Genet; 1995 Apr; 95(4):376-81. PubMed ID: 7705830
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
36. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer.
Hori M; Inagawa S; Shimazaki J; Itabashi M; Hori M
Pathol Res Pract; 2000; 196(12):817-26. PubMed ID: 11156322
[TBL] [Abstract][Full Text] [Related]
38. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
Leers MP; Nap M
Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
[TBL] [Abstract][Full Text] [Related]
39. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
40. Association between GSTP1 genotypes and hormone receptor phenotype in invasive ductal carcinomas of breast.
Khabaz MN; Gari MA; Al-Maghrabi JA; Nedjadi T; Bakarman M
Asian Pac J Cancer Prev; 2015; 16(5):1707-13. PubMed ID: 25773813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
